The burden of cardiovascular disease attributable to high systolic blood pressure across China, 2005-18: a population-based study

被引:18
作者
Cao, Xue [1 ,2 ]
Zhao, Zhenping [3 ]
Kang, Yuting [4 ]
Tian, Yixin [1 ,2 ]
Song, Yuxin [1 ,2 ]
Wang, Limin [3 ]
Zhang, Linfeng [1 ,2 ]
Wang, Xin [1 ,2 ]
Chen, Zuo [1 ,2 ]
Zheng, Congyi [1 ,2 ]
Tian, Lu [5 ]
Yin, Peng [3 ]
Fang, Yuehui [6 ]
Zhang, Mei [3 ]
He, Yuna [6 ]
Zhang, Zugui [7 ]
Weintraub, William S. [8 ]
Zhou, Maigeng [3 ]
Wang, Zengwu [1 ,2 ]
机构
[1] Peking Union Med Coll, Fuwai Hosp, State Key Lab Cardiovasc Dis,Natl Ctr Cardiovasc, Natl Clin Res Ctr Cardiovasc Dis,Div Prevent & Co, Beijing 102308, Peoples R China
[2] Chinese Acad Med Sci, Beijing 102308, Peoples R China
[3] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Beijing Hosp, Off Natl Clin Res Geriatr, Natl Ctr Gerontol,Inst Geriatr Med, Beijing, Peoples R China
[5] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA
[6] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China
[7] Christiana Care Hlth Syst, Newark, DE USA
[8] Georgetown Univ, MedStar Hlth Res Inst, Washington, DC USA
关键词
PRIMARY-HEALTH-CARE; GLOBAL BURDEN; SUBNATIONAL ANALYSIS; HYPERTENSION; MORTALITY; TRENDS; PREVALENCE; ADULTS; NUTRITION; LOST;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Temporal trends and geographical variations in cardiovascular disease attributable to high systolic blood pressure in China are not yet fully understood. The aim of this study was to quantify the cardiovascular disease burden attributable to high systolic blood pressure at national and provincial levels in China. Methods In this population-based study, we evaluated systolic blood pressure and estimated the number of deaths, age-standardised mortality rates, and years of life lost (YLLs) due to cardiovascular disease and its subcategories (including ischaemic heart disease, ischaemic stroke, haemorrhagic stroke, and other cardiovascular diseases) attributable to high systolic blood pressure, at the national level and by 31 provincial levels, in China, from 2005 to 2018. We pooled blood pressure data of 1.30 million adults aged 25 years and older from the China Chronic Disease and Risk Factor Surveillance project, the China National Nutrition Survey, and the China Hypertension Survey. We applied a temporal-spatial Bayesian hierarchical model to estimate age-specific, sex-specific, province-specific, and year-specific average systolic blood pressure, and a comparative risk assessment method to compute the cardiovascular disease burden attributable to high systolic blood pressure by age, sex, year, and province. Findings Nationally, age-standardised mean systolic blood pressure was 132.5 mm Hg (95% uncertainty interval [UI] 124.6-140.3) in men and 129.4 mm Hg (121.7 to 137.2) in women. 2.67 million (95% UI 2.61 to 2.72) cardiovascular disease deaths in China were attributable to high systolic blood pressure, including 1.12 million deaths (1.07 to 1.16) due to ischaemic heart disease, 0.63 million deaths (0.60 to 0.65) due to ischaemic stroke, 0.58 million deaths (0.57 to 0.60) due to haemorrhagic stroke, and 0.34 million deaths (0.32 to 0.36) due to other cardiovascular disease. The age-standardised cardiovascular disease mortality rates associated with high systolic blood pressure were 268.99 per 100 000 people (95% UI 264.11 to 273.51) in 2005 and 220.84 per 100 000 people (216.30 to 224.76) in 2018, a percentage change of -17.90%; the rate changed by an average of -1.50% (95% UI -1.55% to -1.45%) per year from 2005 to 2018 nationally. YLL rates for total cardiovascular disease caused by high systolic blood pressure varied substantially across provinces, ranging from 3078.33 (95% UI 2807.40 to 3303.57) per 100 000 people in Beijing to 7189.98 (95% UI 6817.18 to 7507.99) per 100 000 people in Heilongjiang in 2018. Age-standardised YLL rates for ischaemic heart disease and ischaemic stroke attributable to high systolic blood pressure were particularly high in northeastern provinces, including Heilongjiang, Liaoning, and Jilin. Interpretation The deaths and YLLs for cardiovascular disease attributable to high systolic blood pressure in China increased between 2005 and 2018, and age-standardised cardiovascular disease mortality rates decreased in the same timeframe. Our findings could help policy makers in promoting blood pressure control measures and implementing effective and locally adapted preventive interventions to reduce the prevalence of high systolic blood pressure and reduce the burden of systolic blood pressure-related cardiovascular disease in China. Copyright (c) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
引用
收藏
页码:E1027 / E1040
页数:14
相关论文
共 39 条
  • [1] Sex Differences in Ischemic Heart Disease Advances, Obstacles, and Next Steps
    Aggarwal, Niti R.
    Patel, Hena N.
    Mehta, Laxmi S.
    Sanghani, Rupa M.
    Lundberg, Gina P.
    Lewis, Sandra J.
    Mendelson, Marla A.
    Wood, Malissa J.
    Volgman, Annabelle S.
    Mieres, Jennifer H.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (02):
  • [2] Trends in the Prevalence of Hypertension in Island and Coastal Areas of China: A Systematic Review With Meta-Analysis
    Chen, Xin
    Wei, Wei
    Zou, Safeng
    Wu, Xiaomei
    Zhou, Bo
    Fu, Lingyu
    Wang, Hailong
    Shi, Jingpu
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2014, 27 (12) : 1503 - 1510
  • [3] Communist Party of China Central Committee. State Council, 2022, 14 5 YEAR PLAN HLTH
  • [4] National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants
    Danaei, Goodarz
    Finucane, Mariel M.
    Lin, John K.
    Singh, Gitanjali M.
    Paciorek, Christopher J.
    Cowan, Melanie J.
    Farzadfar, Farshad
    Stevens, Gretchen A.
    Lim, Stephen S.
    Riley, Leanne M.
    Ezzati, Majid
    Abdeen, Ziad
    Agyemang, Charles
    Al Nsour, Mohannad
    Ali, Mohamed M.
    Ambady, Ramachandran
    Babu, Bontha V.
    Barbagallo, Carlo M.
    Barcelo, Alberto
    Barreto, Sandhi M.
    Barros, Henrique
    Bautista, Leonelo E.
    Bjerregaard, Peter
    Bjoerkelund, Cecilia
    Bo, Simona
    Bobak, Martin
    Bonora, Enzo
    Botana, Manuel A.
    Bovet, Pascal
    Breckenkamp, Juergen
    Breteler, Monique M.
    Broda, Grazyna
    Brown, Ian J.
    Bursztyn, Michael
    de Leon, Antonio Cabrera
    Casiglia, Edoardo
    Castetbon, Katia
    Chatterji, Somnath
    Chen, Zhengming
    Chen, Chien-Jen
    Chua, Lily
    Cifkova, Renata
    Cobiac, Linda J.
    Cooper, Richard S.
    Dankner, Rachel S.
    Dong, Guang-Hui
    Elliott, Paul
    Erem, Cihangir
    Esteghamati, Alireza
    Fan, Jian-Gao
    [J]. LANCET, 2011, 377 (9765) : 568 - 577
  • [5] The globalburden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard?
    Egan, Brent M.
    Kjeldsen, Sverre E.
    Grassi, Guido
    Esler, Murray
    Mancia, Guiseppe
    [J]. JOURNAL OF HYPERTENSION, 2019, 37 (06) : 1148 - 1153
  • [6] A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks
    Fang, Evandro F.
    Xie, Chenglong
    Schenkel, Joseph A.
    Wu, Chenkai
    Long, Qian
    Cui, Honghua
    Aman, Yahyah
    Frank, Johannes
    Liao, Jing
    Zou, Huachun
    Wang, Ninie Y.
    Wu, Jing
    Liu, Xiaoting
    Li, Tao
    Fang, Yuan
    Niu, Zhangming
    Yang, Guang
    Hong, Jiangshui
    Wang, Qian
    Chen, Guobing
    Li, Jun
    Chen, Hou-Zao
    Kang, Lin
    Su, Huanxing
    Gilmour, Brian C.
    Zhu, Xinqiang
    Jiang, Hong
    He, Na
    Tao, Jun
    Leng, Sean Xiao
    Tong, Tanjun
    Woo, Jean
    [J]. AGEING RESEARCH REVIEWS, 2020, 64
  • [7] National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants
    Finucane, Mariel M.
    Stevens, Gretchen A.
    Cowan, Melanie J.
    Danaei, Goodarz
    Lin, John K.
    Paciorek, Christopher J.
    Singh, Gitanjali M.
    Gutierrez, Hialy R.
    Lu, Yuan
    Bahalim, Adil N.
    Farzadfar, Farshad
    Riley, Leanne M.
    Ezzati, Majid
    [J]. LANCET, 2011, 377 (9765) : 557 - 567
  • [8] Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
    Forouzanfar, Mohammad H.
    Liu, Patrick
    Roth, Gregory A.
    Ng, Marie
    Biryukov, Stan
    Marczak, Laurie
    Alexander, Lily
    Estep, Kara
    Abate, Kalkidan Hassen
    Akinyemiju, Tomi F.
    Ali, Raghib
    Alvis-Guzman, Nelson
    Azzopardi, Peter
    Banerjee, Amitava
    Baernighausen, Till
    Basu, Arindam
    Bekele, Tolesa
    Bennett, Derrick A.
    Biadgilign, Sibhatu
    Catala-Lopez, Ferran
    Feigin, Valery L.
    Fernandes, Joao C.
    Fischer, Florian
    Gebru, Alemseged Aregay
    Gona, Philimon
    Gupta, Rajeev
    Hankey, Graeme J.
    Jonas, Jost B.
    Judd, Suzanne E.
    Khang, Young-Ho
    Khosravi, Ardeshir
    Kim, Yun Jin
    Kimokoti, Ruth W.
    Kokubo, Yoshihiro
    Kolte, Dhaval
    Lopez, Alan
    Lotufo, Paulo A.
    Malekzadeh, Reza
    Melaku, Yohannes Adama
    Mensah, George A.
    Misganaw, Awoke
    Mokdad, Ali H.
    Moran, Andrew E.
    Nawaz, Haseeb
    Neal, Bruce
    Ngalesoni, Frida Namnyak
    Ohkubo, Takayoshi
    Pourmalek, Farshad
    Rafay, Anwar
    Rai, Rajesh Kumar
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (02): : 165 - 182
  • [9] Partitioning linear trends in age-adjusted rates
    Hankey, BF
    Ries, LA
    Kosary, CL
    Feuer, EJ
    Merrill, RM
    Clegg, LX
    Edwards, BK
    [J]. CANCER CAUSES & CONTROL, 2000, 11 (01) : 31 - 35
  • [10] Racial Differences in the Impact of Elevated Systolic Blood Pressure on Stroke Risk
    Howard, George
    Lackland, Daniel T.
    Kleindorfer, Dawn O.
    Kissela, Brett M.
    Moy, Claudia S.
    Judd, Suzanne E.
    Safford, Monika M.
    Cushman, Mary
    Glasser, Stephen P.
    Howard, Virginia J.
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (01) : 46 - 51